Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction

NCT06077240 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 256

Last updated 2026-03-19

No results posted yet for this study

Summary

The study will recruit an anticipated 256 adults who currently smoke cigarettes and report a willingness to try switching to alternative, non-combustible products. Participants will be randomized to receive either e-cigarettes or nicotine pouches for a duration of 4 weeks and to 1 of 4 possible regulatory scenarios within products where flavor availability is either menthol and tobacco/unflavored available or tobacco/unflavored only available, and nicotine concentration is either higher (5% e-cig, 6mg pouch) or lower (2.4% e-cig, 3mg pouch). Participants will return for bi-weekly research visits (in person or remote videocall) to complete measures for study aims. Participants will complete a final follow-up at Week 6 to assess maintenance of cigarette reduction and willingness to continue using products once they are no longer provided. The investigators expect to observe which products and constituents lead to greater smoking reduction.

Conditions

  • Smoking
  • Smoking Behaviors
  • Nicotine Dependence

Interventions

BEHAVIORAL

E-cigarette with 2.4% Nicotine with Menthol and Tobacco Flavors

Flavor availability is menthol and tobacco/unflavored with lower nicotine concentration.

BEHAVIORAL

E-cigarette with 2.4% Nicotine with Tobacco Flavor Only

Flavor availability is tobacco/unflavored only with lower nicotine concentration.

BEHAVIORAL

E-cigarette with 5% Nicotine with Menthol and Tobacco Flavors

Flavor availability is menthol and tobacco/unflavored with higher nicotine concentration.

BEHAVIORAL

E-cigarette with 5% Nicotine with Tobacco Flavor Only

Flavor availability is tobacco/unflavored only with higher nicotine concentration.

BEHAVIORAL

Tobacco Pouches with 3mg Nicotine with Menthol and Tobacco Flavors

Flavor availability is menthol and tobacco/unflavored with lower nicotine concentration.

BEHAVIORAL

Tobacco Pouches with 3mg Nicotine with Tobacco Flavor Only

Flavor availability is tobacco/unflavored only with lower nicotine concentration.

BEHAVIORAL

Tobacco Pouches with 6mg Nicotine with Menthol and Tobacco Flavors

Flavor availability is menthol and tobacco/unflavored with higher nicotine concentration.

BEHAVIORAL

Tobacco Pouches with 6mg Nicotine with Tobacco Flavor Only

Flavor availability is tobacco/unflavored only with higher nicotine concentration.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • Yale University

    lead OTHER

Principal Investigators

  • Lisa Fucito, PhD · Yale University

  • Krysten Bold, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-20
Primary Completion
2028-04-01
Completion
2028-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06077240 on ClinicalTrials.gov